Scientists at the Korea Advanced Institute of Science and Technology (KAIST) have developed a groundbreaking technology that can transform colon cancer cells back into healthy cells.
Follow for more Interesting Facts, Science videos, Viral News, and Much more.
Researchers at the Korea Advanced Institute of Science and Technology (KAIST) have reportedly developed a new technology that may change how cancer is treated. As reported by ‘Interesting Engineering’, this technology transforms colon cancer cells into cells that resemble normal cells, rather than destroying them. The research was published in -Advanced Science- and led by Professor Kwang-Hyun Cho of the Department of Bio and Brain Engineering
The team created a computer model of the gene network responsible for normal cell development. Using this model, they identified key molecular switches that can revert colon cancer cells back to a normal-like state.
Unlike conventional therapies, which aim to destroy cancer cells, the KAIST team has taken a radically different approach. Their method targets the root cause of cancer development by addressing how cells regress along the differentiation pathway during their transformation into cancerous states.
Using a computational “digital twin” of the gene network involved in cell differentiation, the researchers simulated and analyzed complex gene interactions. This allowed them to identify key molecular switches capable of reverting cancer cells to a normal-like state. Their findings were confirmed through molecular experiments, cellular studies, and animal trials.
Traditional cancer treatments often cause serious side effects and cancer can return. This new approach aims to address these i ..
The researchers believe this method could work for other cancers as well. By using the same computer modeling technology on different cancer gene networks, they hope to find similar molecular switches. Professor Cho explained the potential impact: “This research introduces the novel concept of reversible cancer therapy by reverting cancer to normal cells. It also develops foundational technology for identifying targets for cancer reversion through the systematic analysis of normal cell different ..
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
